NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
NGM Biopharmaceuticals Market Cap: 128.53M for April 5, 2024
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Catalent Inc (DELISTED) | -- |
| AIM ImmunoTech, Inc. | 3.824M |
| Perspective Therapeutics, Inc. | 194.39M |
| Protalix Biotherapeutics, Inc. | 165.27M |
| Armata Pharmaceuticals, Inc. | 209.99M |
Market Cap Related Metrics
| PS Ratio | 28.76 |
| Price to Book Value | 0.8647 |
| Earnings Yield | -112.3% |